title: [Epidural spinal hematoma following thrombolytic therapy for an acute myocardial infarct].
abstract: We describe a case of spinal epidural hematoma in a 58 year old patient who suffered a myocardial infarction and was treated with recombinant tissue plasminogen activator. Computed tomographic and magnetic resonance imaging studies utilized, confirmed the presence of the hematoma. The main signs and symptoms in establishing the presumptive diagnosis and the essential contribution of magnetic resonance in confirming the diagnosis are mentioned. Finally, we review the bleeding complications due to thrombolytic agents and therapeutic prospects and prognosis in this pathology.
authors.affiliation: Servicio de Cardiología, Hospital Regional Carlos Haya, Málaga.
authors.forename: J
authors.initials: J
authors.lastname: Zafra Sánchez
authors.forename: M
authors.initials: M
authors.lastname: de Mora Martín
authors.forename: G
authors.initials: G
authors.lastname: Fernández Madero
authors.forename: J M
authors.initials: JM
authors.lastname: Hernández García
authors.forename: S
authors.initials: S
authors.lastname: Barakat
authors.forename: F
authors.initials: F
authors.lastname: Malpartida
mesh_terms: D000208:Acute Disease; D005343:Fibrinolytic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D006407:Hematoma, Epidural, Cranial / Q000000981:diagnostic imaging / Q000209:etiology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications* / Q000188:drug therapy; D011859:Radiography; D011994:Recombinant Proteins / Q000627:therapeutic use; D010959:Tissue Plasminogen Activator / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D005343:Fibrinolytic Agents; D011994:Recombinant Proteins; D010959:Tissue Plasminogen Activator